- 米国企業
- ALPINE IMMUNE SCIENCES, INC.
ALPINE IMMUNE SCIENCES, INC.ALPN
時価総額
$37.7億
PER
| 2017年 12月31日 | 2018年 12月31日 | 2019年 12月31日 | 2020年 12月31日 | 2021年 12月31日 | 2022年 12月31日 | |
| Collaboration revenue | - | 1 | 2 | 9 | 23 | 30 |
| Research and development | 11 | 29 | 36 | 27 | 59 | 70 |
| General and administrative | 6 | 8 | 9 | 11 | 15 | 18 |
| Total operating expenses | 17 | 39 | 45 | 38 | 73 | 88 |
| Loss from operations | -15 | -38 | -44 | -29 | -50 | -58 |
| Interest income | - | - | 1 | 0 | 0 | 3 |
| Interest expense | 0 | 0 | 0 | 1 | 1 | 0 |
| Other, net | - | - | - | - | -0 | -0 |
| Loss before taxes | -8 | -37 | -42 | -28 | -50 | -55 |
| Income tax benefit (expense) | -200,000 | -0 | - | -0 | -0 | 2 |
| Net loss | -8 | -36 | -42 | -28 | -50 | -58 |
| Unrealized loss on investments | -0 | 0 | 0 | -0 | -0 | -1 |
| Unrealized gain (loss) on foreign currency translation | - | - | -0 | 0 | -0 | 0 |
| Comprehensive loss | -8 | -36 | -42 | -28 | -51 | -59 |
| Earnings Per Share, Basic | - | - | - | - | -1.98 | -1.73 |
| Earnings Per Share, Diluted | - | - | - | - | -1.98 | -1.73 |